Cardiologia Italiana del Territorio

Novità’ dalla letteratura

//Novità’ dalla letteratura
- 01/2016

Aldosterone Predicts Cardiovascular, Renal, and Metabolic Disease in the General Community: A 4‐Year Follow‐Up

gennaio 2016|News, Novità’ dalla letteratura|0 Comments

Abstract Background We recently reported that normal aldosterone levels are associated with cardiovascular, renal, and metabolic disease in a sample of the US general community (Visit 1). For the current analyses we used the same cohort in a new 4‐year follow‐up study (Visit 2). Methods and Results We measured aldosterone at Visit 1 and analyzed

- 01/2016

Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis

gennaio 2016|News, Novità’ dalla letteratura|0 Comments

Summary Background The benefits of blood pressure lowering treatment for prevention of cardiovascular disease are well established. However, the extent to which these effects differ by baseline blood pressure, presence of comorbidities, or drug class is less clear. We therefore performed a systematic review and meta-analysis to clarify these differences. Method For this systematic review

- 11/2015

A NEW DISCOVERY TO DEFINITIVELY REDUCE “BAD” CHOLESTEROL

novembre 2015|Novità’ dalla letteratura|0 Comments

  Amazing! A new vaccine can significantly reduce low-density lipoprotein (LDL) cholesterol (the bad one) in both mice and rhesus macaque monkeys. The study comes from some researchers led by Dr. Bryce Chackerian of the Department of Molecular Genetics and Microbiology at the University of New Mexic and has been published in the scientific journal

- 11/2015

Comparative Performance of ATRIA, CHADS2, and CHA2DS2-VASc Risk Scores Predicting Stroke in Patients With Atrial Fibrillation

novembre 2015|News, Novità’ dalla letteratura|0 Comments

The authors of this study evaluated the effectiveness of CHA2DS2-VASc and CHADS2 scores compared with ATRIA score for predicting stroke risk in 60,594 patients with atrial fibrillation not on warfarin. The ATRIA score had a C statistic of 0.70, which was slightly higher than the C statistic of 0.68 for both the CHADS2 and CHA2DS2-VASc

- 11/2015

PCR and Emergency Cardiovascular Care

novembre 2015|Novità’ dalla letteratura|0 Comments

A Summary of 2015 AHA Guidelines Update for CPR and Emergency Cardiovascular Care CARDIOPULMONARY RESUSCITATION Based on the 2015 American Heart Association (AHA) Guidelines Update for Cardiopulmonary Resuscitation (CPR) and Emergency Cardiovascular Care (ECC)1 Key Points • The guidelines are an update to the 2010 AHA Guidelines for CPR and ECC, incorporating evidence from systematic

- 12/2010

SARTANI E RISCHIO DA TUMORE: La Posizione della SIA

dicembre 2010|Novità’ dalla letteratura|0 Comments

Una metanalisi pubblicata da Lancet Oncology aveva evidenziato un possibile modesto aumento di rischio di sviluppare neoplasie nei pazienti in terapia con sartani. Dopo il commento di Mauro Venegoni del Centro regionale Farmacovigilanza di Milano, diamo spazio ai professori Massimo Volpe e Alberto Morganti che espongono la posizione della Società Italiana di Ipertensione Arteriosa.

- 02/2010

La terapia con fibrati o statine può aumentare il rischio di sanguinamento GI nei soggetti in trattamento con warfarin

febbraio 2010|Novità’ dalla letteratura|0 Comments

di Michelle Rizzo- Medscape-cardiology-news Initiation of a fibrate or statin that inhibits CYP3A4 enzymes -- including fenofibrate, gemfibrozil, fluvastatin, simvastatin, and atorvastatin -- increases the risk of hospitalization for GI bleeding in chronic warfarin users, according to a report in the February issue of the American Journal of Medicine.